Tamoxifen for Nexplanon Bleeding? A New RCT.

from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls

LARCS are endorsed by the ACOG due to the high efficacy. However, unpredictable bleeding can affect continuation rates. A new RCT has evaluated the use of tamoxifen to control and prevent future abnormal bleeding with etonogestrel implant use. Does this work? What is the MOA? In this session, we will summarize this new publication (published ahead of print) in Obstetrics and Gynecology.

Episode metadata supplied by the publisher feed · Published Jul 12, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Tamoxifen for Nexplanon Bleeding? A New RCT.

0:00 13:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr. Chapa’s OBGYN Clinical Pearls?

This episode is 13 minutes long.

When was this Dr. Chapa’s OBGYN Clinical Pearls episode published?

This episode was published on July 12, 2020.

Can I download this Dr. Chapa’s OBGYN Clinical Pearls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!